Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
40
PHI Quote, Financials, Valuation and Earnings
Last price:
$22.16
Seasonality move
:
8.27%
Day range:
$21.88 - $22.64
52-week range:
$21.00 - $29.05
Dividend yield:
7.64%
P/E ratio:
8.56x
P/S ratio:
1.28x
P/B ratio:
2.45x
Volume:
64.3K
Avg. volume:
67.1K
1-year change:
-8.48%
Market cap:
$4.8B
Revenue:
$3.8B
EPS (TTM):
$2.61
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | $3.9B | $3.8B | $3.8B | $3.8B | |
| Revenue Growth (YoY) | 11.68% | 6.86% | -3.8% | 0.97% | -0.24% | |
| Cost of Revenues | $291.3M | $337.3M | $372.3M | $458.2M | $483.4M | |
| Gross Profit | $3.4B | $3.6B | $3.4B | $3.3B | $3.3B | |
| Gross Profit Margin | 92.02% | 91.36% | 90.08% | 87.91% | 87.21% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $921.9M | $933.4M | $941.7M | $830.8M | $736.7M | |
| Other Inc / (Exp) | -$93M | -$36.7M | $443.7M | $73.5M | $43M | |
| Operating Expenses | $2.4B | $2.6B | $3.4B | $2.5B | $2.3B | |
| Operating Income | $938M | $930M | $18M | $810.6M | $955.5M | |
| Net Interest Expenses | $179M | $197.9M | $203.9M | $228.8M | $254.2M | |
| EBT. Incl. Unusual Items | $666M | $695.4M | $257.7M | $655.2M | $744.3M | |
| Earnings of Discontinued Ops. | -- | -$2.5M | -$11M | -$736.5K | -- | |
| Income Tax Expense | $170.3M | $151.4M | $49.5M | $172.7M | $176.7M | |
| Net Income to Company | $666M | $693.3M | $248.1M | $654.5M | $744.3M | |
| Minority Interest in Earnings | -$6M | -$6.3M | -$4.6M | -$3.8M | -$4.3M | |
| Net Income to Common Excl Extra Items | $489.8M | $535.2M | $192.5M | $478.1M | $563.2M | |
| Basic EPS (Cont. Ops) | $2.26 | $2.47 | $0.89 | $2.21 | $2.60 | |
| Diluted EPS (Cont. Ops) | $2.26 | $2.47 | $0.89 | $2.21 | $2.60 | |
| Weighted Average Basic Share | $216.1M | $216.1M | $216.1M | $216.1M | $216.1M | |
| Weighted Average Diluted Share | $216.1M | $216.1M | $216.1M | $216.1M | $216.1M | |
| EBITDA | $1.9B | $2B | $2.3B | $2B | $2B | |
| EBIT | $867.9M | $904.4M | $469.7M | $900.7M | $1B | |
| Revenue (Reported) | $3.7B | $3.9B | $3.8B | $3.8B | $3.8B | |
| Operating Income (Reported) | $938M | $930M | $18M | $810.6M | $955.5M | |
| Operating Income (Adjusted) | $867.9M | $904.4M | $469.7M | $900.7M | $1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $989.9M | $956.3M | $912.2M | $973.2M | $957.5M | |
| Revenue Growth (YoY) | 12.75% | -3.4% | -4.61% | 6.7% | -1.62% | |
| Cost of Revenues | $85M | $89M | $98.9M | $127.4M | $130.3M | |
| Gross Profit | $904.9M | $867.2M | $813.3M | $845.9M | $827.2M | |
| Gross Profit Margin | 91.41% | 90.69% | 89.16% | 86.91% | 86.39% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $302.6M | $209.1M | $192M | $238.3M | $178.6M | |
| Other Inc / (Exp) | $28.4M | $38.1M | $7.5M | $4.6M | $1.3M | |
| Operating Expenses | $773.6M | $657.8M | $1.1B | $809M | $657.8M | |
| Operating Income | $131.3M | $209.4M | -$332.6M | $36.9M | $169.3M | |
| Net Interest Expenses | $47M | $53.1M | $54.4M | $60.5M | $74.2M | |
| EBT. Incl. Unusual Items | $112.7M | $194.4M | -$379.5M | -$19M | $96.5M | |
| Earnings of Discontinued Ops. | -- | -- | -$8.3M | -$499.1K | -- | |
| Income Tax Expense | $15.7M | $41.5M | -$90.3M | $1.4M | $22.3M | |
| Net Income to Company | $102M | $206.1M | -$382.3M | -$15.5M | $96.7M | |
| Minority Interest in Earnings | -$1.7M | -$1.7M | $419.2K | -$1.6M | -$1.6M | |
| Net Income to Common Excl Extra Items | $95.2M | $148.8M | -$297.2M | -$22.5M | $72.6M | |
| Basic EPS (Cont. Ops) | $0.44 | $0.69 | -$1.38 | -$0.11 | $0.33 | |
| Diluted EPS (Cont. Ops) | $0.44 | $0.69 | -$1.38 | -$0.11 | $0.33 | |
| Weighted Average Basic Share | $216M | $216.1M | $216.1M | $216.1M | $216.1M | |
| Weighted Average Diluted Share | $216M | $216.1M | $216.1M | $216.1M | $216.1M | |
| EBITDA | $535.5M | $545.6M | $479.7M | $446.5M | $497.3M | |
| EBIT | $165.4M | $248.3M | -$323.1M | $46.3M | $173.6M | |
| Revenue (Reported) | $989.9M | $956.3M | $912.2M | $973.2M | $957.5M | |
| Operating Income (Reported) | $131.3M | $209.4M | -$332.6M | $36.9M | $169.3M | |
| Operating Income (Adjusted) | $165.4M | $248.3M | -$323.1M | $46.3M | $173.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | $3.9B | $3.7B | $3.8B | $3.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $292M | $337.3M | $370.8M | $458.4M | $483.1M | |
| Gross Profit | $3.4B | $3.6B | $3.4B | $3.3B | $3.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.2B | $1.3B | $1.3B | $1.3B | $1.2B | |
| Other Inc / (Exp) | -$185M | -$136M | $356M | -$94.6M | -$136.8M | |
| Operating Expenses | $2.4B | $2.6B | $3.3B | $2.5B | $2.3B | |
| Operating Income | $935M | $930.3M | $32.8M | $812.3M | $957.8M | |
| Net Interest Expenses | $85.2M | $99.3M | $103.9M | $60.5M | $74.2M | |
| EBT. Incl. Unusual Items | $664.8M | $695M | $284.9M | $657.2M | $746.8M | |
| Earnings of Discontinued Ops. | -- | -- | -$10.6M | -$741K | -- | |
| Income Tax Expense | $169.5M | $151.3M | $55.8M | $173.1M | $177.4M | |
| Net Income to Company | $666M | $693.3M | $248.1M | $654.5M | $744.3M | |
| Minority Interest in Earnings | -$6M | -$6.3M | -$4.7M | -$3.8M | -$4.3M | |
| Net Income to Common Excl Extra Items | $489.3M | $535M | $213.8M | $479.6M | $565M | |
| Basic EPS (Cont. Ops) | $2.26 | $2.47 | $0.99 | $2.22 | $2.61 | |
| Diluted EPS (Cont. Ops) | $2.26 | $2.47 | $0.99 | $2.22 | $2.61 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $2B | $2.1B | $1.9B | $1.9B | $1.9B | |
| EBIT | $938.3M | $935.5M | $145M | $821.8M | $962M | |
| Revenue (Reported) | $3.7B | $3.9B | $3.7B | $3.8B | $3.8B | |
| Operating Income (Reported) | $935M | $930.3M | $32.8M | $812.3M | $957.8M | |
| Operating Income (Adjusted) | $938.3M | $935.5M | $145M | $821.8M | $962M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.9B | $3.7B | $3.8B | $3.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $337.3M | $370.8M | $458.4M | $483.1M | -- | |
| Gross Profit | $3.6B | $3.4B | $3.3B | $3.3B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.3B | $1.3B | $1.3B | $1.2B | -- | |
| Other Inc / (Exp) | -$136M | $356M | -$94.6M | -$136.8M | -- | |
| Operating Expenses | $2.6B | $3.3B | $2.5B | $2.3B | -- | |
| Operating Income | $930.3M | $32.8M | $812.3M | $957.8M | -- | |
| Net Interest Expenses | $99.3M | $103.9M | $60.5M | $74.2M | -- | |
| EBT. Incl. Unusual Items | $695M | $284.9M | $657.2M | $746.8M | -- | |
| Earnings of Discontinued Ops. | -- | -$10.6M | -$741K | -- | -- | |
| Income Tax Expense | $151.3M | $55.8M | $173.1M | $177.4M | -- | |
| Net Income to Company | $693.3M | $248.1M | $654.5M | $744.3M | -- | |
| Minority Interest in Earnings | -$6.3M | -$4.7M | -$3.8M | -$4.3M | -- | |
| Net Income to Common Excl Extra Items | $535M | $213.8M | $479.6M | $565M | -- | |
| Basic EPS (Cont. Ops) | $2.47 | $0.99 | $2.21 | $2.61 | -- | |
| Diluted EPS (Cont. Ops) | $2.47 | $0.99 | $2.21 | $2.61 | -- | |
| Weighted Average Basic Share | $865.2M | $864.9M | $865.3M | $865.3M | -- | |
| Weighted Average Diluted Share | $865.2M | $864.9M | $865.3M | $865.3M | -- | |
| EBITDA | $2.1B | $1.9B | $1.9B | $1.9B | -- | |
| EBIT | $935.5M | $145M | $821.8M | $962M | -- | |
| Revenue (Reported) | $3.9B | $3.7B | $3.8B | $3.8B | -- | |
| Operating Income (Reported) | $930.3M | $32.8M | $812.3M | $957.8M | -- | |
| Operating Income (Adjusted) | $935.5M | $145M | $821.8M | $962M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $837.8M | $465.3M | $452.7M | $291.8M | $171.5M | |
| Short Term Investments | $173.4M | $185.2M | $10.6M | $16.4M | $17M | |
| Accounts Receivable, Net | $459.2M | $424.1M | $471.5M | $470.6M | $541.6M | |
| Inventory | $85.1M | $71.3M | $64.1M | $60.3M | $56.6M | |
| Prepaid Expenses | $221.9M | $247.3M | -- | -- | -- | |
| Other Current Assets | $5.3M | $11.2M | $275.9M | $238.4M | $170.9M | |
| Total Current Assets | $1.8B | $1.4B | $1.5B | $1.3B | $1.1B | |
| Property Plant And Equipment | $5.8B | $6.3B | $5.8B | $5.8B | $6.1B | |
| Long-Term Investments | $1.2B | $1.1B | $1B | $987.9M | $982.8M | |
| Goodwill | $1.3B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Other Intangibles | $82.2M | $22.5M | $28.9M | $25.1M | $26.1M | |
| Other Long-Term Assets | $1.4B | $1.8B | $1.5B | $1.4B | $1.1B | |
| Total Assets | $12B | $12.2B | $11.2B | $11B | $10.7B | |
| Accounts Payable | $1.6B | $1.7B | $1.8B | $1.4B | $1B | |
| Accrued Expenses | $1.4B | $1.3B | $1.2B | $1.1B | $1B | |
| Current Portion Of Long-Term Debt | $365.8M | $223.5M | $579.9M | $210.1M | $399.9M | |
| Current Portion Of Capital Lease Obligations | $84.2M | $88.7M | $188.1M | $106.8M | $125.7M | |
| Other Current Liabilities | $219.2M | $208.8M | $91.3M | $105.4M | $66.9M | |
| Total Current Liabilities | $4.4B | $4.4B | $4.4B | $3.5B | $3.2B | |
| Long-Term Debt | $4.3B | $4.7B | $3.9B | $4.4B | $4.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9.5B | $9.7B | $9.2B | $9B | $8.7B | |
| Common Stock | $33.4M | $31.2M | $28.8M | $28.9M | $27.5M | |
| Other Common Equity Adj | -$741.9M | -$709.2M | -$637.2M | -$761.5M | -$752M | |
| Common Equity | $2.4B | $2.4B | $1.9B | $1.9B | $2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $88.6M | $82.7M | $94M | $93.2M | $22.5M | |
| Total Equity | $2.5B | $2.5B | $2B | $2B | $2B | |
| Total Liabilities and Equity | $12B | $12.2B | $11.2B | $11B | $10.7B | |
| Cash and Short Terms | $1B | $650.5M | $463.3M | $308.3M | $188.5M | |
| Total Debt | $4.6B | $4.9B | $4.5B | $4.6B | $4.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $837.8M | $465.3M | $452.7M | $291.8M | $171.5M | |
| Short Term Investments | $173.4M | $185.2M | $10.6M | $16.4M | $17M | |
| Accounts Receivable, Net | $459.2M | $424.1M | $471.5M | $470.6M | $541.6M | |
| Inventory | $85.1M | $71.3M | $64.1M | $60.3M | $56.6M | |
| Prepaid Expenses | $221.9M | $247.3M | -- | -- | -- | |
| Other Current Assets | $5.3M | $11.2M | $275.9M | $238.4M | $170.9M | |
| Total Current Assets | $1.8B | $1.4B | $1.5B | $1.3B | $1.1B | |
| Property Plant And Equipment | $5.8B | $6.3B | $5.8B | $5.8B | $6.1B | |
| Long-Term Investments | $1.2B | $1.1B | $1B | $987.9M | $982.8M | |
| Goodwill | $1.3B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Other Intangibles | $82.2M | $22.5M | $28.9M | $25.1M | $26.1M | |
| Other Long-Term Assets | $1.4B | $1.8B | $1.5B | $1.4B | $1.1B | |
| Total Assets | $12B | $12.2B | $11.2B | $11B | $10.7B | |
| Accounts Payable | $1.6B | $1.7B | $1.8B | $1.4B | $1B | |
| Accrued Expenses | $1.4B | $1.3B | $1.2B | $1.1B | $1B | |
| Current Portion Of Long-Term Debt | $365.8M | $223.5M | $579.9M | $210.1M | $399.9M | |
| Current Portion Of Capital Lease Obligations | $84.2M | $88.7M | $188.1M | $106.8M | $125.7M | |
| Other Current Liabilities | $219.2M | $208.8M | $91.3M | $105.4M | $66.9M | |
| Total Current Liabilities | $4.4B | $4.4B | $4.4B | $3.5B | $3.2B | |
| Long-Term Debt | $4.3B | $4.7B | $3.9B | $4.4B | $4.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9.5B | $9.7B | $9.2B | $9B | $8.7B | |
| Common Stock | $33.4M | $31.2M | $28.8M | $28.9M | $27.5M | |
| Other Common Equity Adj | -$741.9M | -$709.2M | -$637.2M | -$761.5M | -$752M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | $5.3M | -- | -- | |
| Minority Interest, Total | $88.6M | $82.7M | $94M | $93.2M | $22.5M | |
| Total Equity | $2.5B | $2.5B | $2B | $2B | $2B | |
| Total Liabilities and Equity | $12B | $12.2B | $11.2B | $11B | $10.7B | |
| Cash and Short Terms | $1B | $650.5M | $463.3M | $308.3M | $188.5M | |
| Total Debt | $4.6B | $4.9B | $4.5B | $4.6B | $4.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $666M | $693.3M | $248.1M | $654.5M | $744.3M | |
| Depreciation & Amoritzation | $1B | $1.1B | $1.8B | $1.1B | $980.2M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$8.6M | -$76.1M | -$157.5M | $18.9M | -$161.7M | |
| Change in Inventories | -$20.5M | $1.2M | $7.5M | $10.7M | $540.4K | |
| Cash From Operations | $1.7B | $1.9B | $1.4B | $1.5B | $1.4B | |
| Capital Expenditures | $1.6B | $2.1B | $1.8B | $1.4B | $1.2B | |
| Cash Acquisitions | -$11.7M | -$28.3M | -$19.4M | -$29.4M | -$65.7M | |
| Cash From Investing | -$1.4B | -$2.1B | -$606.1M | -$990.1M | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | -$337.3M | -$359.5M | -$463.4M | -$419M | -$361.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.4B | $1B | $385.6M | $682.6M | $645M | |
| Long-Term Debt Repaid | -$890.4M | -$458M | -$673.7M | -$778.1M | -$494M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$32.1M | -$13.4M | -$3.9M | -$19M | $7.4M | |
| Cash From Financing | $9.3M | -$99.5M | -$776.9M | -$708.1M | -$389.3M | |
| Beginning Cash (CF) | $491.5M | $816.8M | $439M | $452.9M | $282M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $340.3M | -$336.4M | $16.3M | -$157.6M | -$109.9M | |
| Ending Cash (CF) | $811.6M | $485.3M | $463M | $290.6M | $174.5M | |
| Levered Free Cash Flow | $140.7M | -$243.7M | -$355.4M | $131.7M | $234.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $102M | $206.1M | -$382.3M | -$15.5M | $96.7M | |
| Depreciation & Amoritzation | $351.2M | $319.2M | $879.9M | $407.3M | $328M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $188.7M | -$21.5M | -$115M | $56.9M | $11.7M | |
| Change in Inventories | -$3.7M | $25.3M | $17.1M | -$12.5M | -$23.1M | |
| Cash From Operations | $377.7M | $472.1M | $456.9M | $365.2M | $234.7M | |
| Capital Expenditures | $310.8M | $424.9M | $354.1M | $215.9M | $340M | |
| Cash Acquisitions | -$10.5M | -$1M | $38.5M | -$28.1M | -$1.2M | |
| Cash From Investing | -$178M | -$433.6M | -$139.3M | -$64.3M | -$320.7M | |
| Dividends Paid (Ex Special Dividend) | $10.8M | -$6.2M | -$17.1M | -$2.9M | $685.6K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $260.8M | $307.5M | $120.3M | $57.8M | $203M | |
| Long-Term Debt Repaid | -$291.7M | -$43.9M | -$258.5M | -$403.8M | -$160.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$4.8M | -$4.4M | -$14.9M | $6.3M | $83M | |
| Cash From Financing | -$69.6M | $71.4M | -$213.9M | -$395.1M | $67.3M | |
| Beginning Cash (CF) | $688.6M | $360.7M | $349.1M | $383.3M | $215M | |
| Foreign Exchange Rate Adjustment | -$291.3K | $326.2K | -$7.2M | -$1.4M | -$21.2M | |
| Additions / Reductions | $130.1M | $109.9M | $103.6M | -$94.2M | -$18.7M | |
| Ending Cash (CF) | $811.6M | $485.3M | $463M | $290.6M | $174.5M | |
| Levered Free Cash Flow | $66.8M | $47.2M | $102.7M | $149.3M | -$105.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $666M | $693.3M | $248.1M | $654.5M | $744.3M | |
| Depreciation & Amoritzation | $1B | $1.1B | $1.8B | $1.1B | $980.2M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$8.6M | -$76.1M | -$157.5M | $18.9M | -$161.7M | |
| Change in Inventories | -$20.5M | $1.2M | $7.5M | $10.7M | $540.4K | |
| Cash From Operations | $1.7B | $1.9B | $1.4B | $1.5B | $1.4B | |
| Capital Expenditures | $1.6B | $2.1B | $1.8B | $1.4B | $1.2B | |
| Cash Acquisitions | -$11.7M | -$28.3M | -$19.4M | -$29.4M | -$65.7M | |
| Cash From Investing | -$1.4B | -$2.1B | -$606.1M | -$990.1M | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | -$337.3M | -$359.5M | -$463.4M | -$419M | -$361.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.4B | $1B | $385.6M | $682.6M | $645M | |
| Long-Term Debt Repaid | -$890.4M | -$458M | -$673.7M | -$778.1M | -$494M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$32.1M | -$13.4M | -$3.9M | -$19M | $7.4M | |
| Cash From Financing | $9.3M | -$99.5M | -$776.9M | -$708.1M | -$389.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $340.3M | -$336.4M | $16.3M | -$157.6M | -$109.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $140.7M | -$243.7M | -$355.4M | $131.7M | $234.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $693.3M | $248.1M | $654.5M | $744.3M | -- | |
| Depreciation & Amoritzation | $1.1B | $1.8B | $1.1B | $980.2M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$76.1M | -$157.5M | $18.9M | -$161.7M | -- | |
| Change in Inventories | $1.2M | $7.5M | $10.7M | $540.4K | -- | |
| Cash From Operations | $1.9B | $1.4B | $1.5B | $1.4B | -- | |
| Capital Expenditures | $2.1B | $1.8B | $1.4B | $1.2B | -- | |
| Cash Acquisitions | -$28.3M | -$19.4M | -$29.4M | -$65.7M | -- | |
| Cash From Investing | -$2.1B | -$606.1M | -$990.1M | -$1.1B | -- | |
| Dividends Paid (Ex Special Dividend) | -$359.5M | -$463.4M | -$419M | -$361.7M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1B | $385.6M | $682.6M | $645M | -- | |
| Long-Term Debt Repaid | -$458M | -$673.7M | -$778.1M | -$494M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$13.4M | -$3.9M | -$19M | $7.4M | -- | |
| Cash From Financing | -$99.5M | -$776.9M | -$708.1M | -$389.3M | -- | |
| Beginning Cash (CF) | $2.3B | $2B | $1.6B | $961.3M | -- | |
| Foreign Exchange Rate Adjustment | $5M | $7.6M | -$4.7M | $2.4M | -- | |
| Additions / Reductions | -$336.4M | $16.3M | -$157.6M | -$109.9M | -- | |
| Ending Cash (CF) | $2B | $2B | $1.4B | $847.1M | -- | |
| Levered Free Cash Flow | -$243.7M | -$355.4M | $131.7M | $234.4M | -- | |
Get PHI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PHI
Sector
P/E ratio
8.56x
17.32x
PEG ratio
0.48x
0.01x
P/B ratio
2.45x
1.43x
Price / LTM sales
1.28x
0.93x
Growth Metrics
PHI
Sector
Revenue growth
-1.62%
1.32%
Earnings growth
0.25%
7.04%
Revenue (5-year growth)
2.95%
1.7%
Earnings forecast
--
$0.13
Profitability
PHI
Sector
Profitability FY 2024
$3.3B
$337.2M
Return on invested capital
8.53%
0.37%
Return on assets
5.19%
0%
Return on equity
28.71%
1.79%
Earnings Date
Last Earnings Date
Mar
5
Next Earnings Date
May
9
Estimated Next Earnings Date
Jun
4
Balance Sheet
PHI
Sector
Total cash
$188.5M
$104.5M
Short term investments
$17M
$40.1M
Total assets
$10.7B
$938.3M
Long term debt
$4.8B
$49.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
54
CNXC alert for Mar 29
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Sell
44
CAR alert for Mar 29
Avis Budget Group [CAR] is up 0.71% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
